Search Results
Feb 05, 2026, 09:00 ET Elevate Capital Promotes Ben Nahir to Partner
Elevate Capital proudly announces the promotion of Ben Nahir, PhD, to Partner, recognizing his exceptional leadership and significant contributions to Elevate Capital and the entrepreneurial community.
More news about: Elevate Capital
Feb 05, 2026, 08:07 ET Ocean Tomo Bolsters Radio Frequency, Wireless, and Spectrum Expertise with Addition of Director Dan Sleeter
Tim Dorney PhD, Technical Lead, Patent Analysis and Reverse Engineering. "Our clients rely on us for precise, defensible interpretations of highly complex technologies,
More news about: J.S. Held
Feb 05, 2026, 08:01 ET For the Third Consecutive Year, Virginia Cancer Specialists Named #1 Practice in Virginia for Cancer Care, and Ranked #1 Across All Medical Specialties
Alexander I. Spira, MD, PhD, FACP, FASCO, Medical Oncology
More news about: Virginia Cancer Specialists
Feb 05, 2026, 08:00 ET Calico Appoints Joseph R. Arron, M.D., Ph.D., as Head of Human Biology and Genetics
multimedia:https://www.prnewswire.com/news-releases/calico-appoints-joseph-r-arron-md-phd-as-head-of-human-biology-and-genetics-302679635.htmlSOURCE
More news about: Calico Life Sciences LLC
Feb 05, 2026, 06:00 ET PhotonPharma Inc. Announces Recruitment for Phase 1 Clinical Trial of Innocell™ Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
targeted immune responses against their cancer."We are excited to begin enrolling patients in this groundbreaking trial," said Raymond P. Goodrich, PhD, Chief Executive Officer and Chief Scientific Officer of PhotonPharma. "Innocell represents a fundamentally different approach to cancer immunotherapy,
More news about: PhotonPharma Inc.
Feb 05, 2026, 04:09 ET HanchorBio Accelerates Global Clinical Footprint with Multiple Oral and Poster Presentations in Q1 2026
poster presentations at premier global forums like AACR-IO and ESMO-TAT reflects the significant momentum of our clinical programs," said Alvin Luk, PhD, MBA, CCRA, President & Chief Medical Officer (Group) and CEO (U.S.A.) of HanchorBio. "By presenting data on both HCB101 and HCB301, we are demonstrating
More news about: HanchorBio Inc.
Feb 05, 2026, 00:00 ET Galaxy Brain Scientific's Technology Enables Landmark Parkinson's Study Published in Nature, Redefining Disease Mechanism
effectively than ever—potentially slowing or reversing its progression, rather than just suppressing symptoms," said co-author Nico U. Dosenbach, MD, PhD, the David M. & Tracy S. Holtzman Professor of Neurology at WashU Medicine.This pioneering study was enabled by Galaxy Brain Scientific's
More news about: Galaxy Brain Scientific Inc.
Feb 04, 2026, 20:01 ET Unlikely Collaborators Hosts Spark Salon with Futures Designer Nick Foster on Rethinking How We Imagine the Future
Kaufman, PhD, nutrition therapist Kim Shapira, MS, RD, mythologist John Bucher, Harvard Business School professor and author Michael Norton, PhD, visionary violinist Vijay Gupta, chef and entrepreneur Ellen Bennett, artist Candy Chang, digital workplace expert and author Alexandra Samuel, PhD, grief experts
More news about: Unlikely Collaborators
Feb 04, 2026, 17:16 ET Beong-Soo Kim Unanimously Elected 13th President of USC
instrumental in cultivating support for our research and elevating awareness for our groundbreaking advances to cure blindness," said Mark Humayun, MD, PhD, Director of the USC Dr. Allen and Charlotte Ginsburg Institute for Biomedical Therapeutics and Co-Director of USC Roski Eye Institute. "I strongly believe
More news about: University of Southern California
Feb 04, 2026, 17:16 ET Beong-Soo Kim Unanimously Elected 13th President of USC
instrumental in cultivating support for our research and elevating awareness for our groundbreaking advances to cure blindness," said Mark Humayun, MD, PhD, Director of the USC Dr. Allen and Charlotte Ginsburg Institute for Biomedical Therapeutics and Co-Director of USC Roski Eye Institute. "I strongly believe
More news about: University of Southern California
Feb 04, 2026, 12:28 ET The Inner Circle acknowledges Jessica L. Ables as a Pinnacle Professional Member
acknowledges respected mentors who have shaped her scientific and clinical perspective including Eric Nestler, MD, PhD, Paul Kenny, PhD, James Murrough, MD, PhD, Andy Stewart, MD, and Ines Ibanez-Tallon, PhD.Looking ahead, Dr. Ables aims to continue advancing discoveries from the laboratory into clinical
More news about: The Inner Circle
Feb 04, 2026, 12:00 ET New Study: Payer Blocking Strategies Delay Care for One in Five Migraine Patients
patients faces repeated denials for prescribed medications, the result is more emergency visits, hospitalizations, and suffering," said Dawn C. Buse, PhD, lead author and clinical professor of neurology at Albert Einstein College of Medicine. "These insurance barriers don't just delay care — they undermine
More news about: The Headache & Migraine Policy Forum
Feb 04, 2026, 11:37 ET Die Queen Elizabeth's School in Gurugram ernennt Gründungsdirektor und Gründungsleiterin der Prep School
Phasen zielgerichteter Veränderungen begleitet. Seine Führungslaufbahn umfasst auch leitende akademische Positionen in den USA und Indonesien. Mit einem PhD in Soziologie verfügt Dr. Cook über eine ausgeprägte interkulturelle Perspektive und engagiert sich intensiv dafür, Studierende auf Führungsaufgaben,
More news about: Queen Elizabeth's Global Schools
Feb 04, 2026, 10:11 ET Unnecessary Cervical Cancer Screening Persists in Women Over 65
targeted quality improvement and education efforts aimed at reducing unnecessary care."These patterns are not simply academic," said Julie Scherer, PhD, Motive's Chief Solutions Officer. "They translate into avoidable procedures, wasted healthcare resources, and patient harm -- exactly the outcomes that
More news about: Motive Medical Intelligence
Feb 04, 2026, 09:00 ET PRN® Pharmacal Celebrates Inaugural Veterinary Technician Awards Winner Following VMX 2026; Invites Continued Nominations Ahead of WVC
development opportunities. "Veterinary technicians are essential to the success of every practice," said Dr. Heather A. Davis, DVM, PhD, DACVS-LA, Director of Clinical Affairs and Veterinary Services. "Recognizing our first award recipient at VMX was a meaningful milestone for PRN
More news about: Pegasus/PRN Pharmacal
Feb 04, 2026, 09:00 ET Variable Rate of Anticoagulation Response to Direct Oral Anticoagulants (DOACs) in Acute Ischemic Stroke: The Potential of Point-of-Care DOAC Anticoagulation Measurement
Neurosurgery."We commend the investigators for demonstrating ClotChek's ability to better inform clinical decision-making in AIS patients," said Sasha Bakhru, PhD, co-author and CEO of Perosphere. "These findings reinforce the value of our point-of-care ClotChek coagulometer in delivering a rapid assessment of
More news about: Perosphere Technologies Inc.
Feb 04, 2026, 09:00 ET U.S. Space Force Taps Workera to Build the Nation's AI-Ready Space Workforce
demonstrate verified mastery across key focus areas."The Space Force is setting a new standard in military talent management," said Jennifer Tucker, PhD, the Assessments and Job Analysis Branch Chief with the Enterprise Talent Management Office at the U.S. Space Force. "Workera's skills intelligence will
More news about: Workera
Feb 04, 2026, 08:54 ET Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors
multimedia:https://www.prnewswire.com/news-releases/lumicell-appoints-biotech-and-medtech-leader-cheryl-r-blanchard-phd-to-board-of-directors-302679028.htmlSOURCE
More news about: Lumicell, Inc.
Feb 04, 2026, 08:45 ET Volition Sponsors Symposium at 15th Conference of the European Hidradenitis Suppurativa Foundation
approach through NETs Plasma Biomarker‑driven personalized treatment" will be presented by Professor Evangelos J. Giamarellos-Bourboulis, M.D., PhD, at the 4th Department of Internal Medicine, ATTIKON University General Hospital, Athens, Greece.Professor Evangelos J. Giamarellos-Bourboulis
More news about: VolitionRx Limited
Feb 04, 2026, 08:44 ET Allergy Research Group Announces Peer-Reviewed Publication Advancing Thyroid and Endocrine Integration Science
ARG's Medical Affairs Team and Scientific Advisory Board, including Allison B. Sayre, MS; Lara Zakaria, ND, MPH; Shawn Tassone, PhD; Alexander Rinehart, PhD; and Richard Harris, PhD. The research presents an integrative framework for understanding how the endocrine system coordinates energy utilization,
More news about: Allergy Research Group
Feb 04, 2026, 08:30 ET Annals of Family Medicine: Studies Evaluate Food-Based and Medication Affordability Interventions for Diabetes Management
Control in Socioeconomically Disadvantaged Patients With DiabetesAyelet Prigozin, PhD; Matan J. Cohen, MD, PhD; Ofri Mosenzon, MD; Hila Mendelovich, RN; Ahlam Natsheh, RN; Amir Shmueli, PhD; Anat Tsur, MD; and Amnon Lahad, MD.Annals of Family Medicine is an open access, peer-reviewed,
More news about: Annals of Family Medicine
Feb 04, 2026, 08:30 ET Maximizing Value in Early-Phase Oncology Trials: Innovative Endpoints for Early Insights, Upcoming Webinar Hosted by Xtalks
Officer; Anu Bansal, MD, MS, VP Medical Imaging, Oncology; Robert Kleiman, MD, Chief Scientific and Regulatory Officer, Cardiac Safety; and Kelly Dumais, PhD, Senior Director and Global Head of eCOA Science and Consulting, for the live webinar on Wednesday, February 25, 2026, at 11am EST (5pm CET/EU-Central).For
More news about: Xtalks
Feb 04, 2026, 08:08 ET Aminex Therapeutics Announces Multiple Sites Activated for Phase 1b/2 Clinical Trial of Novel Investigational Cancer Treatment AMXT 1501 and DFMO in Patients with Breast Cancer or Melanoma
"Initiating this study is an important milestone for Aminex and for patients facing advanced cancers with limited treatment options," said Mark Burns, PhD, Chief Scientific Officer and President of Aminex. "This trial builds on our foundation of pre- and early clinical data demonstrating the potential of
More news about: Aminex Therapeutics, Inc.
Feb 04, 2026, 08:00 ET Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer
of Biomica, Evogene expects to benefit from BMC128's future success."Dr. Jing Bao, MD, a Director (Board Member) of Biomica Ltd with a PhD from the Weizmann Institute of Science, stated: "We are very pleased to see the execution of this meaningful and impactful collaboration agreement. This
More news about: Evogene; Shanghai Lishan Biopharmaceuticals Co., Ltd.
Feb 04, 2026, 07:00 ET Third Arc Bio Announces $52M Series A Extension to Expand Oncology and Immunology & Inflammation Portfolio
our expanding oncology portfolio while rapidly advancing our next-generation I&I assets into first-in-human studies," said Peter F. Lebowitz, MD, PhD, Chief Executive Officer of Third Arc Bio. "By parallel-tracking programs, we can more efficiently validate the full potential of our platforms, rapidly
More news about: Third Arc Bio